INS and Hyperglycemia: Pioglitazone and rosiglitazone belong to the class of peroxisome proliferator-activated receptor agonists, also known as glitazones or thiazolidinediones, with the ability to improve insulin-sensitivity and reduce hyperglycemia, in addition to promising vascular effect resulting from experimental studies [66].